心臓幹細胞療法です. 効率と安全性のモニタリングの最適化の必要性
Peter Oettgen1, Andrew J Boyle, Steven P Schulman
1Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA. joettgen@bidmc.harvard.edu
Circulation
|July 26, 2006
まとめ
No abstract available in PubMed .


